🔗 Share this article

The prestigious award in medical science has been granted for revolutionary findings that illuminate how the body's defense network attacks dangerous pathogens while sparing the body's own cells.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this accolade.

Their research identified unique "sentinels" within the immune system that eliminate rogue defense cells that could attacking the organism.

The findings are now paving the way for new therapies for autoimmune diseases and malignancies.

These laureates will share a prize fund valued at 11 million SEK.

Decisive Discoveries

"Their work has been essential for comprehending how the body's defenses operates and why we don't all suffer from severe autoimmune diseases," commented the chair of the Nobel Committee.

The team's studies explain a core question: In what way does the defense system protect us from countless infections while keeping our healthy cells intact?

The body's protection system uses immune cells that search for indicators of infection, even viruses and bacteria it has never encountered.

Such cells employ sensors—known as recognition units—that are produced by chance in countless combinations.

This gives the immune system the capacity to combat a broad range of threats, but the randomness of the mechanism inevitably produces immune cells that can target the body.

Security Guards of the Immune System

Scientists previously understood that a portion of these harmful defense cells were eliminated in the thymus—the site where white blood cells mature.

The latest award recognizes the identification of regulatory T-cells—known as the immune system's "security guards"—which travel through the body to neutralize other defenders that attack the body's own tissues.

We know that this process fails in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

The prize committee added, "The discoveries have laid the foundation for a novel area of research and spurred the development of new therapies, for example for cancer and autoimmune diseases."

Regarding malignancies, T-regs prevent the system from fighting the tumor, so studies are aimed at lowering their quantity.

For autoimmune diseases, experiments are testing boosting regulatory T-cells so the organism is not under attack. A comparable method could also be effective in minimizing the chances of organ transplant rejection.

Pioneering Studies

Professor Shimon Sakaguchi, of a Japanese institution, conducted experiments on mice that had their thymus extracted, leading to self-attack conditions.

The researcher showed that introducing immune cells from other animals could stop the disease—suggesting there was a mechanism for blocking immune cells from attacking the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at a biotech firm in San Francisco, were studying an inherited autoimmune disease in mice and humans that resulted in the identification of a genetic factor vital for the way regulatory T-cells operate.

"The groundbreaking research has revealed how the body's defenses is controlled by T-reg cells, preventing it from accidentally attacking the body's own tissues," commented a prominent physiology expert.

"This work is a remarkable illustration of how fundamental biological study can have far-reaching implications for public health."